April 19, 2018 11:42 PM ET


Company Overview of Afferent Pharmaceuticals, Inc.

Company Overview

Afferent Pharmaceuticals, Inc. researches and develops drugs for the treatment of debilitating neurogenic disorders. It develops P2X3, a purinergic receptor that plays a role in the sensitization of nerves; AF-219, a selective P2X3 antagonist for the treatment of pathologic cough; and P2X3 antagonist that blocks P2X3 in the carotid body. It offers programs in the areas of respiratory diseases, resistant hypertension, P2X3 biology, cardiovascular diseases, and chronic pain and other indications; and clinical trials. The company was founded in 2009 and is based in San Mateo, California. As of July 26, 2016, Afferent Pharmaceuticals, Inc. operates as a subsidiary of Merck & Co., Inc.

2929 Campus Drive

Suite 230

San Mateo, CA 94403

United States

Founded in 2009





Key Executives for Afferent Pharmaceuticals, Inc.

Chief Executive Officer and Director
Age: 63
Co-Founder & Chief Scientific Officer
Chief Medical Officer
Age: 67
Vice President of Clinical Operations
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Afferent Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.